Article

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients

1996-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5094c8c0-7fa0-50c2-871d-e91a6979af92
DOI: 10.1016/0168-9525(96)81379-5

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patientsDOI 10.1016/0168-9525(96)81379-5Read

Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA <sup>−</sup> Immunodeficient PatientsSemantic proximity Read

T Lymphocyte-Directed Gene Therapy for ADA <sup>−</sup> SCID: Initial Trial Results After 4 YearsSemantic proximity Read

Gene therapy for PIDs: Progress, pitfalls and prospectsSemantic proximity Read

Gene therapy for primary immunodeficienciesSemantic proximity Read

Gene therapy for adenosine deaminase severe combined immune deficiency—An unexpected journey of four decadesSemantic proximity Read

Update on gene therapy for immunodeficienciesSemantic proximity Read

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiencySemantic proximity Read

Gene Therapy for Primary ImmunodeficienciesSemantic proximity Read

Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiencySemantic proximity Read

Gene therapy and genome editing for primary immunodeficiency diseasesSemantic proximity Read

Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapySemantic proximity Read

Concise Review: Lessons Learned From Clinical Trials of Gene Therapy in Monogenic Immunodeficiency DiseasesSemantic proximity Read